Sr One Capital Management, LP reported 17 holdings worth US$1.15B as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Sr One Capital Management, LP reported 17 holdings worth US$1.15B as of Sep 30, 2026. Largest: Veradermics, Incorporated, ADARx Pharmaceuticals, Inc. and Zenas BioPharma, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 17
- Value as reported
- US$1.15B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Veradermics, Incorporated | 2.08M | US$252M | 21.9% |
| ADARx Pharmaceuticals, Inc. | 9.94M | US$198M | 17.2% |
| Zenas BioPharma, Inc. | 5.04M | US$136M | 11.8% |
| Avalyn Pharma Inc. | 3.31M | US$94.3M | 8.2% |
| Odyssey Therapeutics, Inc. | 3.79M | US$84.3M | 7.3% |
| Design Therapeutics, Inc. | 6.53M | US$82M | 7.1% |
| ORIC Pharmaceuticals, Inc. | 4.62M | US$62.2M | 5.4% |
| Mineralys Therapeutics, Inc. | 1.56M | US$39.3M | 3.4% |
| Mobia Medical, Inc. | 1.99M | US$18.8M | 1.6% |
| ARS Pharmaceuticals, Inc. | 4.01M | US$17.3M | 1.5% |
| Alumis Inc. | 1.96M | US$14.5M | 1.3% |
| Nkarta, Inc. | 3.33M | US$8.73M | 0.76% |
| Ultragenyx Pharmaceutical Inc. | 138K | US$2.07M | 0.18% |
| enGene Holdings Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC